Kaveri Parker

Chief Business Officer at Synedgen

Dr. Parker leads the commercialization and business development of all Synedgen product divisions, including Wound Care and Prisyna Oral Care, and assists in the expansion of strategic partnership opportunities across the spectrum of Synedgen’s product portfolio. Dr. Parker has an extensive background in biochemistry and infectious diseases, as well as years of business development and management experience. Most recently, she served as President and Chief Executive Officer of ID Genomics Inc. in Seattle, WA, where she led all aspects of executive management, including strategic and tactical planning, fundraising, path-to-market strategy, investor and media relations, as well as R&D capability scale-up. During her tenure, she secured strategic partnerships with 12 major clinical hospital networks across the U.S. and leveraged ID Genomics’ technology into an international microbial surveillance network.

Timeline

  • Chief Business Officer

    Current role

View in org chart